Milliporesigma Brochures

  1. CDMO Services: Customized Lipids And LNP Solutions 5/21/2026

    This view of lipid and LNP development shows how experience, global GMP‑ready manufacturing, and flexible collaboration models support programs from preclinical through commercialization.

  2. Enhance Dissolution Rate With A Single High Performance Excipient 5/5/2026

    Enhance dissolution and lubrication in solid oral formulations. See how this approach supports poorly soluble actives, modern manufacturing methods, and consistent performance.

  3. BioRepository Services 3/20/2026

    Reliable sample protection comes from secure facilities. Learn how multiple storage formats, split‑site options, and full audit trails help ensure biological materials remain ready for future use.

  4. Empower Your Studies With Our Expertise 3/18/2026

    Look at how optimized virus banking strengthens manufacturing by enhancing consistency, speeding characterization timelines, and aligning testing strategies with modern regulatory expectations.

  5. Starting Point Of Every Success Story 3/18/2026

    Reliable cell banks are essential for protecting research quality. See how expert support and structured processes help maintain cell line integrity, reduce risk, and strengthen development.

  6. Ensure Complete Characterization Of Your Rodent Cell Line 3/13/2026

    Targeted NGS brings fast detection of rodent viruses to cell line characterization. Discover an automated workflow that supports reliable identification and helps teams strengthen contamination control.

  7. High‑Purity Nucleoside Triphosphates 3/13/2026

    High‑purity nucleoside triphosphates are essential for reliable mRNA production. Learn more about their quality specifications, consistency, and regulatory support for production workflows.

  8. Chemicals For mRNA Drug Manufacturing 3/13/2026

    Get a clear overview of high-quality chemicals and lipids that support each step of pDNA and mRNA manufacturing, helping streamline processes, strengthen consistency, and enable reliable LNP formulation.

  9. Gene Therapy Capabilities For AAV And Lentivirus Production Platforms 3/9/2026

    Get a clear look at the sequential steps behind robust AAV and lentiviral manufacturing, highlighting key process decisions and practical considerations for building reliable gene therapy workflows.

  10. NGS AAT For Cell Line Characterization 2/24/2026

    A modern sequencing‑based assay strengthens cell line characterization with greater sensitivity. See how it supports confident, objective safety decisions and helps reduce risk during early development.